Skip to main content
Premium Trial:

Request an Annual Quote

Margaret Peterlin, Carlos Gutierrez, Dennis Hastert, Richard Armey, Judge Jerry Smith, Mike Edwards, Geeta Vemuri, Sangeeta Bhatia, Todd Lorenz

Margaret Peterlin, deputy under secretary of commerce for intellectual property and deputy director of the United States Patent and Trademark Office, said this week that she will be leaving the USPTO in August with plans to pursue employment in the private sector.
US Secretary of Commerce Carlos Gutierrez appointed Peterlin as deputy under secretary in early 2007 (see BTW, 6/4/2007).
Prior to joining the USPTO, Peterlin was counsel for legal policy and national security advisor for Dennis Hastert, speaker of the US House of Representatives. Previously she was general counsel to Richard Armey, majority leader of the House. She has clerked on the Fifth Circuit Court of Appeals for Judge Jerry Smith, and served as an officer in the US Navy for four years, working in communications. Peterlin holds a legal degree from the University of Chicago and is a member of the New York State Bar.

Mike Edwards has been named associate vice president for research in the Office of Research Technology Management at Case Western Reserve University, the school said this week.
Edwards, who has served as assistant vice president and director of the Office of Research at the University of Notre Dame since 2004, will be charged with helping CWRU increase its research profile beyond Northeast Ohio and enhancing its participation in large-scale, multi-partner projects, CWRU said.
Edwards was involved in Notre Dame’s research development and technology transfer programs since 2000. He also spent 24 years in the US Army before retiring from service as a lieutenant colonel. Edwards holds a master of public administration from Golden Gate University in San Francisco, and master degrees in administration and business administration from Notre Dame.

Quaker BioVentures this week said that it has promoted Geeta Vemuri to the position of partner.
Vemuri joined Quaker as a senior associate in 2003, before being promoted to vice president, and later principal. Prior to joining Quaker, Vemuri was an associate at Toucan Capital, and has also served as an associate analyst at Salomon Smith Barney and First Union Securities. Prior to this, she was a research scientist at the Wistar Institute and postdoctoral fellow at Thomas Jefferson University.
Vemuri is a former board member of Protez Pharmaceuticals, which was recently acquired by Novartis; and is currently a member of the board of directors at Argolyn BioSciences, Cellatope, and Immune Control.

Millipore this week announced that Sangeeta Bhatia, a biomedical engineer in the department of medicine at Brigham and Women’s Hospital, is the first recipient of the Millipore Seed Grant Fellowship, which the company recently established in partnership with the Harvard Stem Cell Institute.
In 2008, Bhatia will receive $100,000 of the $500,000 Millipore grant to HSCI, which was announced in September. Bhatia will be eligible for continued funding in 2009. The funds will be used to support her research in the area of embryonic stem cell differentiation.
Bhatia, who is also a professor of health sciences and technology, and electrical engineering and computer science at the Massachusetts Institute of Technology, holds an MD from Harvard Medical School, and a PhD in biomedical engineering from MIT.

Patent lawyer Todd Lorenz has joined King & Spaulding as a partner in the law firm’s San Francisco office.
Lorenz joins King & Spaulding from Dorsey & Whitney, where he was a partner and served as co-chair of Dorsey’s life sciences practice.

Lorenz earned a BS from Rensselaer Polytechnic Institute and a JD from Boston University School of Law.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.